• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside.

作者信息

Nanjundappa Aravinda, Raza Jaffar Ali, Dieter Robert S, Mandapaka Sangeeta, Cascio Wayne E

机构信息

East Carolina University, Department of Internal Medicine, Division of Cardiology, 600 Moye Blvd, TA 378, Greenville, NC 27834, USA.

出版信息

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):125-31. doi: 10.1586/14779072.5.1.125.

DOI:10.1586/14779072.5.1.125
PMID:17187464
Abstract

Cell transplantation is an innovative technology that involves the implantation of a variety of myogenic and angiogenic cell types. The transplanted cells proliferate and augment left ventricular performance and therein ameliorate the heart failure symptoms. The concept of cell transplantation has followed the footsteps of angiogenesis starting as bench side research. The latter half of the decade saw the transformation of this potential mechanism to a promising therapy for ischemic heart failure. More than 150 patients have been treated with cellular transplantation worldwide. This novel application has the potential to revolutionize alternative therapeutic approaches to management of heart failure.

摘要

相似文献

1
Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside.
Expert Rev Cardiovasc Ther. 2007 Jan;5(1):125-31. doi: 10.1586/14779072.5.1.125.
2
Cellular transplantation: future therapeutic options.细胞移植:未来的治疗选择。
Curr Opin Cardiol. 2007 Mar;22(2):104-10. doi: 10.1097/HCO.0b013e3280210657.
3
Cellular transplantation: new horizons in the surgical management of heart failure.细胞移植:心力衰竭外科治疗的新视野
J R Coll Surg Edinb. 2002 Dec;47(6):749-52.
4
Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine.骨髓基质细胞移植后急性心肌梗死中的新生血管形成与心肌细胞再生:猪梗死相关动脉与非梗死相关动脉途径的比较
Clin Chim Acta. 2007 Jun;381(2):114-8. doi: 10.1016/j.cca.2007.02.035. Epub 2007 Feb 23.
5
Stem cell therapy for the treatment of heart failure.用于治疗心力衰竭的干细胞疗法。
Curr Opin Cardiol. 2007 Sep;22(5):464-70. doi: 10.1097/HCO.0b013e3282c3cb2a.
6
Left ventricular restoration: how important is the surgical treatment of ischemic heart failure trial?左心室修复:缺血性心力衰竭试验的外科治疗有多重要?
Heart Fail Clin. 2007 Apr;3(2):237-43. doi: 10.1016/j.hfc.2007.04.009.
7
Cell transplantation: a novel perspective in the treatment of heart failure.细胞移植:治疗心力衰竭的新视角。
Ital Heart J. 2004 Jun;5 Suppl 6:108S-115S.
8
[Cardiac cellular therapy: from cells to the first clinical uses].[心脏细胞治疗:从细胞到首次临床应用]
Arch Mal Coeur Vaiss. 2005 Jun;98(6):637-48.
9
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的心内膜单极电压升高与左心室功能改善之间的关联。
Tex Heart Inst J. 2016 Aug 1;43(4):291-6. doi: 10.14503/THIJ-15-5341. eCollection 2016 Aug.
10
Cell transplantation for post-ischemic heart failure.用于缺血性心力衰竭的细胞移植。
Arch Mal Coeur Vaiss. 2002 Dec;95(12):1219-25.

引用本文的文献

1
PD-L1 and AKT Overexpressing Adipose-Derived Mesenchymal Stem Cells Enhance Myocardial Protection by Upregulating CD25 T Cells in Acute Myocardial Infarction Rat Model.PD-L1 和 AKT 过表达脂肪间充质干细胞通过上调急性心肌梗死大鼠模型中的 CD25 T 细胞增强心肌保护作用。
Int J Mol Sci. 2023 Dec 21;25(1):134. doi: 10.3390/ijms25010134.
2
Therapeutic effects of adipose derived fresh stromal vascular fraction-containing stem cells versus cultured adipose derived mesenchymal stem cells on rescuing heart function in rat after acute myocardial infarction.脂肪源性含新鲜基质血管成分的干细胞与培养的脂肪源性间充质干细胞对急性心肌梗死后大鼠心脏功能挽救的治疗效果比较
Am J Transl Res. 2019 Jan 15;11(1):67-86. eCollection 2019.
3
Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction.
嵌入富血小板纤维蛋白支架的脂肪来源间充质干细胞可促进血管生成、维持心脏功能并减少大鼠急性心肌梗死后的左心室重构。
Am J Transl Res. 2015 May 15;7(5):781-803. eCollection 2015.
4
Global transcriptional analysis for biomarker discovery and validation in cellular therapies.用于细胞疗法中生物标志物发现与验证的全转录组分析。
Mol Diagn Ther. 2009;13(3):181-93. doi: 10.2165/01250444-200913030-00003.
5
Potency analysis of cellular therapies: the emerging role of molecular assays.细胞疗法的效力分析:分子检测的新兴作用
J Transl Med. 2007 May 30;5:24. doi: 10.1186/1479-5876-5-24.